期刊文献+

中国汉族人群高血压脑出血患者NFATC1基因rs754093多态性观察 被引量:1

NFATC1 gene rs754093 polymorphism associated with hypertensive cerebral hemorrhage in Han population of China
下载PDF
导出
摘要 目的观察中国汉族人群高血压脑出血患者活化T细胞核因子1(NFATC1)基因rs754093的多态性。方法选择中国汉族人脑出血患者230例(观察组)和健康体检者233例(对照组),采用多聚酶链反应—限制性内切酶片段长度多态性技术(PCR-RFLP)检测其血清中NFATC1基因rs754093的多态性。结果观察组基因型T/T、T/G、G/G及等位基因T、G的频率分别为34.1%、48.3%、17.4%、58.5%、41.5%,对照组分别为44.2%、44.6%、11.2%、66.5%、33.5%,两组比较,P均<0.05。分析显示,相对于携带TT基因型者,携带GG+TG基因型者脑出血发病风险增加51.4%;相对于携带T等位基因,携带G等位基因脑出血发病风险增加41.1%。结论中国汉族人群高血压脑出血患者NFATC1基因rs754093存在多态性,其中携带G/G基因型者易发生脑出血。 Objective To investigate NFATC1 gene rs754093 polymorphism associated with hypertensive cerebral hemorrhage in Han population of China. Methods The subject of observe group were consecutively recruited from northern China region patients with a total of 230 cases. The controls were health people with a total of 233 cases. The snp rs754093 of NFATC1 was genotyped by PCR-RFLP. Results THE observe group T / T, T / G ,G/G genotype frequencies and T,G allele frequencies were 34. 1% ,48.3%, 17.4% ,58.5% ,41.5% separately, the controls group were 44.2% ,44.6%, 11.2% ,66.5 % ,33.5% separately. There was significam difference between two groups ( P 〈 0.05 ). Comparing with TT genotype , the GG + TG genotype could increase 51. 4% of the risk of cerebral hemorrhage. Compare with T allele the G allele can increase 41.1% of the risk of cerebral hemorrhage,. Conclusions NFATC1 gene rs754093 polymorphism is associated with hypertensive cerebral hemorrhage in Han population of China. The G / G genotype is the independent risk factor of cerebral hemorrhage in Han population of China.
出处 《山东医药》 CAS 北大核心 2011年第2期7-9,共3页 Shandong Medical Journal
关键词 活化T细胞核因子1 脑出血 单核苷酸多态性 高血压病 nuclear factor of activated T cells 1 intracerebral hemorrhage single nucleotide polymorphism hypertemion
  • 相关文献

参考文献7

  • 1孙淑云,李江,张晨.血小板活化因子乙酰水解酶基因突变(Val279-Phe)与急性脑出血的相关性研究[J].神经疾病与精神卫生,2003,3(2):112-114. 被引量:5
  • 2Julia M, Orsbal, Khalil. Reduced endothelial NO-cGMP-Mdiated 4 Vascular Relaxation and Hypertension in IL-6 Infused PreRates[ J]. Hypertension,2004,439 ( 11 ) :434-444.
  • 3Catto A, Carter AM, Barrett JH, et al. Angiotensin convertingenzyme insertion deletion polymorphism and eerebrovascular disease [J].Stroke, 1996,27 ( 3 ) :435 -440.
  • 4Ueda S, Weir C J, Inglis GC, et al. Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke[ J]. J Hypertens, 1995,13 (12Pt2) : 1597-1601.
  • 5Zee RY, Ridker PM, Stampfer M.I, et al. Prospective evaluation of theangiotensin converting enzyme insertion deletion polymorphism and the risk of stroke[ J]. Circulation, 1999,99( 3 ) :340-343.
  • 6Reiner AP, Schwartz SM, Frank MB, et al. Polymorphisms ofcoagulation factorX III subunit A and risk of nonfatal hemorrhagic stroke in young white women[ J]. Stroke,2001,32 ( 11 ) :2580-2586.
  • 7Puri RD,Tewari S, Sinha N, et al. Polymorphisms in the apolipoprotein B-100 gene: association with plasma lipid concentration and coro-nary artery disease[ J]. Indian Heart J ,2003,55 ( 1 ) :60-64.

二级参考文献8

  • 1Yoshida H,Imaizumi T,Fujimoto K,et al.Amutation in plasm a platelet-activating factor acetylhydrolase(Val279-Phe) is a genetic risk fac tor for cerebral hemorrhage but not for hypertension[].Thrombosis and Haemostasis.1998
  • 2Hiramoto MD,Hidemi Yoshida H,Imaizumi T,et al.A mutation in plasma platelet-activating factor acetylhydrolase(Val279-Phe)is a genetic risk factor for stroke[].Stroke.1997
  • 3Stofforini DM,Satoh K,Atkinson DL,et al.Platelet-activating factor acetylhydrolase deficiency: A missense mutation near the active site of an anti-inflammatory phospholipase[].The Journal of Clinical Investigation.1996
  • 4Muirhead EE.Antihypertensive functions of the kidney[].Journal of Hypertension.1980
  • 5Stofforini DM,Prescott SM,Mclntyre TM,et al.Human plasma platelet-activating factor acetylhydrolase: Purification and properties[].Journal of Biological Chemistry.1987
  • 6Caramero C,Fernamdez Gallarado SD,Marin Cao D,et al.Presence of Platelet-activating factor in blood from human and experimental animals,Its absence in anephric individuals[].Biochemical and Biophysical Research Communications.1984
  • 7Kawaguchi H,Yasuda H.Effects of platelet-activating factor on coversion of angiotensin I to II[].FEBS Letters.1987
  • 8Stremler KE,Staforini DM,Prescott SM,et al.An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma[].Journal of Biological Chemistry.1989

共引文献4

同被引文献19

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部